Helix Holds First Close of Expected $200M Series B Financing

Helix, a San Carlos, CA-based personal genomics company that has created an online store for DNA-powered products, held the first close of an expected $200m Series B financing.

The round was led by DFJ Growth, with participation from Illumina, Kleiner Perkins Caufield Byers, Mayo Clinic, Sutter Hill Ventures, and Warburg Pincus. In conjunction with the funding, Barry Schuler, Partner at DFJ Growth and former Chairman and CEO of America Online, will join the Helix Board of Directors.

The company will use the funds to to continue to accelerate consumer adoption of genomics via the expansion of its marketplace.

Led by Robin Thurston, CEO, Helix operates an online marketplace for DNA-powered products, which features world-class partners, all committed to developing innovative health-focused products powered by Next Generation Sequencing.
Today, the store includes 35 products from 20 partners. Each product is evaluated by the Helix scientific team and must meet the requirements of the company’s Scientific Evidence Evaluation (SEE) process, which evaluates the underlying scientific content and claims of each partner product.

The company collects and sequences a DNA sample once, and then securely stores and protects a customer’s data so they can access additional DNA-powered products and services from the store without providing another saliva sample.




Join the discussion